[Citalopram]

Dtsch Med Wochenschr. 2003 Oct 24;128(43):2253-6. doi: 10.1055/s-2003-43098.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antidepressive Agents, Second-Generation* / adverse effects
  • Antidepressive Agents, Second-Generation* / pharmacokinetics
  • Antidepressive Agents, Second-Generation* / pharmacology
  • Antidepressive Agents, Second-Generation* / therapeutic use
  • Citalopram* / adverse effects
  • Citalopram* / pharmacokinetics
  • Citalopram* / pharmacology
  • Citalopram* / therapeutic use
  • Depressive Disorder / drug therapy*
  • Humans
  • Panic Disorder / drug therapy*
  • Selective Serotonin Reuptake Inhibitors* / adverse effects
  • Selective Serotonin Reuptake Inhibitors* / pharmacokinetics
  • Selective Serotonin Reuptake Inhibitors* / pharmacology
  • Selective Serotonin Reuptake Inhibitors* / therapeutic use

Substances

  • Antidepressive Agents, Second-Generation
  • Serotonin Uptake Inhibitors
  • Citalopram